⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARGX News
argenx SE American Depositary Shares
Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent Member
businesswire.com
NVO
ARGX
American Kidney Fund Launches New Kidney Transplant Resources to Help Patients Navigate Evaluation, Surgery and Recovery
globenewswire.com
ARGX
BIIB
argenx to Host Autoimmune Myositis R&D Webinar
globenewswire.com
ARGX
argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026
globenewswire.com
ARGX
argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026
globenewswire.com
ARGX
Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight
globenewswire.com
IMVT
ROIV
MRK
NVS
REGN
UCB
JNJ
ARGX
AMGN
VIR
IPHA
ARWR
APLS
CABA
argenx to Host Myositis R&D Webinar on June 23, 2026
globenewswire.com
ARGX
argenx to Present at Upcoming Investor Conferences
globenewswire.com
ARGX
Vyvgart Hytrulo (Argenx) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
ARGX
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
globenewswire.com
ARGX